PATENT CLAIM ANALYSIS

Application Number: 16004994
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "425000"]

Abstract:
The present invention is related to a compound of formula (I): a pharmaceutically acceptable salt thereof, a hydrate thereof, a solvate thereof, a metabolite thereof or a prodrug thereof;for use in a method for the treatment and/or prevention of cancer, wherein X is selected from the group consisting of N—R 1 , O and S; R 1  is selected from the group consisting of alkyl, cycloalkyl, aryl, arylalkyl and hydrogen; R 2  is selected from the group consisting of indolyl, substituted indolyl, azaindolyl and substituted azaindolyl; and R 3  is selected from the group consisting of aryl, substituted aryl, unsubstituted heteroaryl, heterocyclyl and substituted heterocyclyl.

Claim (Index 108):
The method of  claim 103 , wherein the compound has an antiproliferative effect on cells of the cancer.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 94.0
- Lexical Diversity: 2.1
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14651053', '14650939', '13761712', '15329175', '11350335']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.803366922341181
- 35 USC 102 Novelty (BERT): 0.5622865211824466
- Combined Prediction Score: 0.7792588822253076
- Mean Citation Score: 332.876572
- Max Citation Score: 455.78223
- Similarity Product: 345.4849480679584

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test